By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agenovir Corporation 

7000 Shoreline Court
Suite 320
South San Francisco  California  94080  U.S.A.
Phone: 650-287-3300 Fax: n/a


SEARCH JOBS

Agenovir is a leader in the research and development of a novel class of human therapeutics to address diseases associated with, or caused by, latent or persistent viral reservoirs. The individuals affected by these diseases number in the millions, and treatment options are extremely limited.

Using its deep virology expertise and targeted genome editing technologies, including CRISPR/Cas9, Agenovir’s mission is to develop innovative treatments that disrupt or eliminate pathogenic viral genomes, bringing hope to patients who suffer from devastating, persistent viral infection.

YEAR FOUNDED:

2014

LEADERSHIP:

Founder, Chair of the Scientific Advisory Board: Stephen Quake, Ph.D.

President and CEO: Dirk Thye, M.D.

Director, Research: Derek Sloan, M.D.

Director, Intellectual Property: William M. Smith, J.D., M.P.A.

TECHNOLOGY:

Please click here for Agenovir's technology.


Key Statistics


Email: aquilatan@agenovir.com
Ownership: Private

Web Site: Agenovir
Employees:
Symbol: 
 









Company News
//-->